Clinical Trial Update: Effect of Oxytocin and Vasopressin Antagonists on Uterine Contractions [Phase 2]

View source ↗

Summary

This Phase 2 trial examined oxytocin and vasopressin antagonists for modulating uterine contractions in IVF treatment and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Oxytocin receptor antagonist (atosiban)
• Vasopressin receptor antagonist

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: In Vitro Fertilisation (IVF) Treatment | Phase 2 | Status: COMPLETED